804 related articles for article (PubMed ID: 33956361)
21. Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients.
Eftekhar SP; Kazemi S; Barary M; Javanian M; Ebrahimpour S; Ziaei N
Cardiovasc Ther; 2021; 2021():6683098. PubMed ID: 33688374
[TBL] [Abstract][Full Text] [Related]
22. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
[TBL] [Abstract][Full Text] [Related]
23. Effects of hydroxychloroquine treatment on QT interval.
Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
[TBL] [Abstract][Full Text] [Related]
24. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19.
Koh HM; Chong PF; Tan JN; Chidambaram SK; Chua HJ
J Clin Pharm Ther; 2021 Jun; 46(3):800-806. PubMed ID: 33768612
[TBL] [Abstract][Full Text] [Related]
25. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
[TBL] [Abstract][Full Text] [Related]
26. Carbon monoxide poisoning increases Tpeak-Tend dispersion and QTc dispersion.
Eroglu M; Uz O; Isilak Z; Yalcin M; Yildirim AO; Kardesoglu E
Cardiovasc J Afr; 2014; 25(3):106-9. PubMed ID: 25000439
[TBL] [Abstract][Full Text] [Related]
27. The impact of hydroxychloroquine and azithromycin on the corrected qt interval in patients with the novel Coronavirus disease 2019.
Murat B; Akgun H; Akarsu M; Ozmen A; Murat S
Rev Assoc Med Bras (1992); 2021 Jul; 67(7):979-984. PubMed ID: 34817510
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
[TBL] [Abstract][Full Text] [Related]
29. Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study.
El Kadri M; Al Falasi O; Ahmed R; Al Awadhi A; Altaha Z; Hillis A; Panikkaveetil B; Abdalla S; Ansel Benette H; Almubarak A; Saifuddin M; Alattar Y; Oulhaj A; AlKaabi S
BMJ Open; 2022 Feb; 12(2):e051579. PubMed ID: 35140148
[TBL] [Abstract][Full Text] [Related]
30. Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.
Gunay S; Caliskan S; Sigirli D; Sahin E
Bratisl Lek Listy; 2020; 121(11):817-821. PubMed ID: 33164544
[TBL] [Abstract][Full Text] [Related]
31. Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis.
Oscanoa TJ; Vidal X; Kanters JK; Romero-Ortuno R
Int J Antimicrob Agents; 2020 Dec; 56(6):106212. PubMed ID: 33164789
[TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
Giaime P; Guenoun M; Pedinielli N; Narbonne H; Bergounioux JP; Solas C; Guilhaumou R; Sampol J; Ollier J; Sichez H; Serveaux M; Brunner F; Bataille S
Nephrol Dial Transplant; 2020 Aug; 35(8):1346-1353. PubMed ID: 32844224
[TBL] [Abstract][Full Text] [Related]
33. Tpeak - Tend and Tpeak - Tend /QT ratio as markers of ventricular arrhythmia risk in cardiac resynchronization therapy patients.
Barbhaiya C; Po JR; Hanon S; Schweitzer P
Pacing Clin Electrophysiol; 2013 Jan; 36(1):103-8. PubMed ID: 23106253
[TBL] [Abstract][Full Text] [Related]
34. Markers of ventricular repolarization as an additional non-invasive electrocardiography parameters for predicting ventricular tachycardia/fibrillation in patients with Brugada Syndrome - A systematic review and meta-analysis.
Pranata R; Yonas E; Vania R; Huang I
Indian Pacing Electrophysiol J; 2019; 19(6):205-210. PubMed ID: 31238124
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19.
Yenerçağ M; Arslan U; Doğduş M; Günal Ö; Öztürk ÇE; Aksan G; Erdoğan G; Gül S; Yontar OC; Şen A
J Electrocardiol; 2020; 62():5-9. PubMed ID: 32731139
[TBL] [Abstract][Full Text] [Related]
36. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
[TBL] [Abstract][Full Text] [Related]
37. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
[TBL] [Abstract][Full Text] [Related]
38. Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death.
Panikkath R; Reinier K; Uy-Evanado A; Teodorescu C; Hattenhauer J; Mariani R; Gunson K; Jui J; Chugh SS
Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):441-7. PubMed ID: 21593198
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.
Shah RR
J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089
[TBL] [Abstract][Full Text] [Related]
40. Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues.
Wong AO; Gurung B; Wong WS; Mak SY; Tse WW; Li CM; Lieu DK; Costa KD; Li RA; Hajjar RJ
J Mol Cell Cardiol; 2021 Apr; 153():106-110. PubMed ID: 33373642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
